Literature DB >> 8012192

Deficiency of the 50 kDa dystrophin-associated glycoprotein and abnormal expression of utrophin in two south Asian cousins with variable expression of severe childhood autosomal recessive muscular dystrophy.

C A Sewry1, A Sansome, K Matsumura, K P Campbell, V Dubowitz.   

Abstract

Two male cousins with severe childhood, autosomal recessive, Duchenne-like, muscular dystrophy (SCARMD) have been identified with a deficiency of the 50 kDa dystrophin-associated glycoprotein but normal expression of dystrophin. Both boys were from consanguineous marriages and were Asian, having originated from Pakistan. This is in contrast to all previously reported cases from North Africa. Clinical severity varied and the patients were still able to walk at 13 and 12 yr, respectively. Neither had calf hypertrophy, a feature reported to be almost consistent in the North African patients. Abnormal expression of utrophin, the dystrophin-related protein, was observed on the surface of several non-regenerating muscle fibres, with less intense immunolabelling in the clinically more affected child. This family shows that SCARMD is not confined to North Africa and illustrates a hitherto unreported expression of utrophin in this condition.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8012192     DOI: 10.1016/0960-8966(94)90003-5

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  3 in total

Review 1.  Increasing complexity of the dystrophin-associated protein complex.

Authors:  J M Tinsley; D J Blake; R A Zuellig; K E Davies
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-30       Impact factor: 11.205

2.  From proteins to genes: immunoanalysis in the diagnosis of muscular dystrophies.

Authors:  Rita Barresi
Journal:  Skelet Muscle       Date:  2011-06-24       Impact factor: 4.912

3.  A mutation in the dystrophin gene selectively affecting dystrophin expression in the heart.

Authors:  F Muntoni; L Wilson; G Marrosu; M G Marrosu; C Cianchetti; L Mestroni; A Ganau; V Dubowitz; C Sewry
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.